HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
6,830.00
+30.00 (0.44%)
Nov 17, 2026, 3:30 PM KST
| Market Cap | 224.02B -4.0% |
| Revenue (ttm) | 253.85B +44.9% |
| Net Income | 3.37B -25.0% |
| EPS | 100.36 -29.1% |
| Shares Out | 32.80M |
| PE Ratio | 68.06 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 227,750 |
| Open | 6,670.00 |
| Previous Close | 6,800.00 |
| Day's Range | 6,600.00 - 6,980.00 |
| 52-Week Range | 6,000.00 - 22,250.00 |
| Beta | 0.20 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 20, 2026 |